| Pralatrexate studied in …STUDIED_INderived39 of 39show fewer |
|---|
| → studied in | NCT06561048Phase 3 · recruiting Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma · 39 trials list this drug (9 active) | — | — | Systemic Anaplastic Large Cell Lymphoma,T-Cell Non-Hodgkin Lymphoma,Follicular Helper T-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01947140Phase 1/Phase 2 · terminated Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies · 39 trials list this drug (9 active) | — | — | Lymphoma,Hodgkin Lymphoma,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06072131Phase 3 · recruiting To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691450Phase 1 · not yet recruiting Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma · 39 trials list this drug (9 active) | — | — | Anaplastic Large Cell Lymphoma,Hepatosplenic T-Cell Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598998Phase 1/Phase 2 · active not recruiting Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas · 39 trials list this drug (9 active) | — | — | Anaplastic Large Cell Lymphoma,Follicular Lymphoma,Hepatosplenic T-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225985Phase 1/Phase 2 · recruiting Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma · 39 trials list this drug (9 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240211Phase 1 · active not recruiting Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL · 39 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07036133Phase 1 · recruiting Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment · 39 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04747236Phase 2 · recruiting Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL · 39 trials list this drug (9 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01626664Phase 2 · completed KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) · 39 trials list this drug (9 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01206465Phase 1 · completed Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors · 39 trials list this drug (9 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336933Phase 2 · completed Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma · 39 trials list this drug (9 active) | — | — | Anaplastic Large Cell Lymphoma,Hepatosplenic T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03161223Phase 1/Phase 2 · recruiting Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma · 39 trials list this drug (9 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01420679Phase 3 · terminated Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00998946Phase 2 · completed Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma · 39 trials list this drug (9 active) | — | — | B-Cell Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052442Phase 1/Phase 2 · completed 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma · 39 trials list this drug (9 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02594267Phase 1 · completed A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00606502Phase 2 · completed Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment · 39 trials list this drug (9 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789723Phase 1 · withdrawn Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn · 39 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820091Phase 1 · withdrawn Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn® · 39 trials list this drug (9 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00481871Phase 1/Phase 2 · completed Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies · 39 trials list this drug (9 active) | — | — | B-Cell Malignant Neoplasm,Hodgkin Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01118624Phase 2 · completed Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer · 39 trials list this drug (9 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00554827Phase 1 · completed Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · 39 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00364923Phase 2 · completed Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134341Phase 1 · completed Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · 39 trials list this drug (9 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mycosis Fungoides+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00722553Phase 2 · completed Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder · 39 trials list this drug (9 active) | — | — | Transitional Cell Carcinoma,Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03349333Phase 3 · completed A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL · 39 trials list this drug (9 active) | — | — | T-Cell Non-Hodgkin Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03355768Phase 3 · withdrawn Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL · 39 trials list this drug (9 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01482962Phase 3 · completed Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01188876Phase 1/Phase 2 · completed Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer · 39 trials list this drug (9 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01178944Phase 2 · completed Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer · 39 trials list this drug (9 active) | — | — | Malignant Gastric Neoplasm,Esophageal Squamous Cell Carcinoma,Gastric Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03356678completed Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma · 39 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013362Phase 1/Phase 2 · completed Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03150602Phase 4 · unknown A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy · 39 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01114282Phase 1 · completed Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM · 39 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532011Phase 1 · completed Erlotinib in Combination With Pralatrexate in Advanced Malignancies · 39 trials list this drug (9 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129206Phase 2 · completed Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy · 39 trials list this drug (9 active) | — | — | Esophageal Neoplasm,Malignant Esophageal Neoplasm,Esophageal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024245Phase 1 · completed 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors · 39 trials list this drug (9 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004238Phase 2 · completed 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer · 39 trials list this drug (9 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |